MENU

Sawai today for
a healthier tomorrow.

We are a generic pharmaceutical company dedicated to lowering cost
and providing solutions for patients in need around the world.

ABOUT US

We Are
SAWAI

Here’s a quick glance at Sawai.
Learn about who we are and what we are doing for you.

Stock
Quotes

Stock Quotes

View More Stock Information

Financials

Financials

Financial Highlights

Cash Flow

Per Share Information

Other
Latest
IR Reports

Latest IR Reports

Nov. 08. 2019

Summary of Financial Results for the 1st Half of FY 2019

Nov. 08. 2019

Financial Results for the 1st Half of FY 2019

Nov. 12. 2019

Financial Results for the 1st Half of FY 2019（Webcast）

Aug. 06. 2019

Summary of Financial Results for the 1st Quarter of FY 2019

Aug. 06. 2019

Financial Results for the 1st Quarter of FY 2019

Learn More

Transparency
Sustainability

Our Commitment
to Transparency

To ensure we create a relationship with our consumers, we are transparent with all of our inner workings in order to push innovation by working with all of our stakeholders.

View All

Sustainability
Initiatives

We will contribute to the realization of an environmentally responsible society through our application of sustainable business practices and our role in the further development of a superior healthcare system.

View All

Latest
News

Latest News

Nov. 08. 2019

Sawai Reports First Half of FY2019 Financial Results

Oct. 08. 2019

Upsher-Smith Launches Tosymra™ (sumatriptan) Nasal Spray for the Acute Treatment of Migraine in Adults

Sep. 06. 2019

Upsher-Smith Launches Morphine Sulfate Tablets

Aug. 28. 2019

MHLW Approves Additional Indications for CANDESARTAN Tablets and OD Tablets2

Aug. 15. 2019

Sawai Receives Approvals for Two Generic Drugs with Five Strengths

Learn More

Integrated
report

Integrated
Report

Integrated Report
[ Year Ended March 31, 2019 ]

Integrated Report

Financial Section

Integrated Report

Integrated Report
[ Year Ended March 31, 2019 ]

View More

Sawai today for
a healthier tomorrow.